Zhu X, Dong W, Zhang M
J Cell Commun Signal. 2024; 18(1):e12016.
PMID: 38545258
PMC: 10964940.
DOI: 10.1002/ccs3.12016.
Vanacker J, Forcet C
Oncogene. 2023; 43(6):379-387.
PMID: 38129506
DOI: 10.1038/s41388-023-02899-w.
Cerutti C, Shi J, Vanacker J
Int J Mol Sci. 2023; 24(5).
PMID: 36901694
PMC: 10002233.
DOI: 10.3390/ijms24054265.
Kadkhoda S, Eslami S, Hussen B, Ghafouri-Fard S
Front Genet. 2022; 13:973585.
PMID: 36147505
PMC: 9486161.
DOI: 10.3389/fgene.2022.973585.
Loudig O, Mitchell M, Ben-Dov I, Liu C, Fineberg S
Breast Cancer Res. 2022; 24(1):62.
PMID: 36096802
PMC: 9469592.
DOI: 10.1186/s13058-022-01558-4.
miR-137/ERRα axis mediates chemoresistance of nasopharyngeal carcinoma cells.
Liu F, Gao C, Wang W, Hu J, Huang Z, Liang M
J Cell Commun Signal. 2021; 16(1):103-113.
PMID: 34196940
PMC: 8688621.
DOI: 10.1007/s12079-021-00634-2.
Clinical value of microRNA-135a and MMP-13 in colon cancer.
Zhou X, Yang D, Ding X, Xu P
Oncol Lett. 2021; 22(2):583.
PMID: 34122634
PMC: 8190779.
DOI: 10.3892/ol.2021.12844.
Transcriptional Regulation of ROS Homeostasis by the ERR Subfamily of Nuclear Receptors.
Scholtes C, Giguere V
Antioxidants (Basel). 2021; 10(3).
PMID: 33809291
PMC: 7999130.
DOI: 10.3390/antiox10030437.
Estrogen-related receptors: novel potential regulators of osteoarthritis pathogenesis.
Tang J, Liu T, Wen X, Zhou Z, Yan J, Gao J
Mol Med. 2021; 27(1):5.
PMID: 33446092
PMC: 7809777.
DOI: 10.1186/s10020-021-00270-x.
Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.
Grzywa T, Klicka K, Wlodarski P
Cancers (Basel). 2020; 12(12).
PMID: 33321819
PMC: 7763175.
DOI: 10.3390/cancers12123709.
MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy.
Cao Z, Qiu J, Yang G, Liu Y, Luo W, You L
Cancer Biol Med. 2020; 17(3):569-582.
PMID: 32944391
PMC: 7476096.
DOI: 10.20892/j.issn.2095-3941.2020.0033.
Perspectives on the Role of Non-Coding RNAs in the Regulation of Expression and Function of the Estrogen Receptor.
Taheri M, Shoorei H, Dinger M, Ghafouri-Fard S
Cancers (Basel). 2020; 12(8).
PMID: 32759784
PMC: 7465269.
DOI: 10.3390/cancers12082162.
Regulation of the expression of the estrogen related receptors (ERRs).
Crevet L, Vanacker J
Cell Mol Life Sci. 2020; 77(22):4573-4579.
PMID: 32448995
PMC: 11104921.
DOI: 10.1007/s00018-020-03549-0.
Serum microRNA-135a as a diagnostic biomarker in non-small cell lung cancer.
Zou Y, Jing C, Liu L, Wang T
Medicine (Baltimore). 2019; 98(50):e17814.
PMID: 31852062
PMC: 6922492.
DOI: 10.1097/MD.0000000000017814.
LncRNA DANCR promotes the proliferation, migration, and invasion of tongue squamous cell carcinoma cells through miR-135a-5p/KLF8 axis.
Zheng Y, Zheng B, Meng X, Yan Y, He J, Liu Y
Cancer Cell Int. 2019; 19:302.
PMID: 31827393
PMC: 6862788.
DOI: 10.1186/s12935-019-1016-6.
Automatic discovery of 100-miRNA signature for cancer classification using ensemble feature selection.
Lopez-Rincon A, Martinez-Archundia M, Martinez-Ruiz G, Schoenhuth A, Tonda A
BMC Bioinformatics. 2019; 20(1):480.
PMID: 31533612
PMC: 6751684.
DOI: 10.1186/s12859-019-3050-8.
Biotransformation of the Mycotoxin Zearalenone to its Metabolites Hydrolyzed Zearalenone (HZEN) and Decarboxylated Hydrolyzed Zearalenone (DHZEN) Diminishes its Estrogenicity In Vitro and In Vivo.
Fruhauf S, Novak B, Nagl V, Hackl M, Hartinger D, Rainer V
Toxins (Basel). 2019; 11(8).
PMID: 31434326
PMC: 6722729.
DOI: 10.3390/toxins11080481.
HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells.
Klinge C, Piell K, Tooley C, Rouchka E
Sci Rep. 2019; 9(1):9430.
PMID: 31263129
PMC: 6603045.
DOI: 10.1038/s41598-019-45636-8.
Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.
Kokabu T, Mori T, Matsushima H, Yoriki K, Kataoka H, Tarumi Y
Cell Oncol (Dordr). 2019; 42(2):223-235.
PMID: 30706380
DOI: 10.1007/s13402-019-00423-5.
Extracellular Vesicles as Transmitters of Hypoxia Tolerance in Solid Cancers.
Zonneveld M, Keulers T, Rouschop K
Cancers (Basel). 2019; 11(2).
PMID: 30699970
PMC: 6406242.
DOI: 10.3390/cancers11020154.